PUF Ventures Inc. (“PUF” or the “Company”) (CNSX:PUF.CN) (Frankfurt:PU3) (OTCPK:PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to congratulate the team at Cannvas MedTech Inc. (CNSX:MTEC.CN) (Frankfurt:3CM) for the launch of Cannvas.Me, an unbiased educational resource for medicinal and adult-use cannabis users which is now available online at http://Cannvas.Me.
In September 2017, PUF announced the spin-off of certain assets to form a company which subsequently became Cannvas MedTech.
“I would like to congratulate Shawn Moniz and Steve Loutskou of Cannvas MedTech on the launch of their first commercial online platform,” said Derek Ivany, President and CEO of PUF Ventures. “We are on the eve of legalization and the cannabis space in Canada is in need of information and education that people can trust and rely on. Using advanced technology, Shawn and Steve have built an impressive web portal that delivers physician vetted content for both medicinal and recreational cannabis users. I wish Shawn and Steve and the rest of their team the very best on a successful launch and continued growth of their remarkable web portal.”
Cannvas MedTech designs and builds customer-centric solutions that enable partners and clients to harness the power of data to truly understand their customers, industry, and key business drivers. The PUF spinout company has established itself as a leading business technology company in the cannabis health sciences space and began trading on the Canadian Stock Exchange with the symbol MTEC on July 3, 2018, and on the Frankfurt Exchange with the symbol 3CM on July 18, 2018.
Its first offering, Cannvas.Me, is a scalable, patient-centric life sciences learning platform for the global medical cannabis industry. Patients, consumers, medical practitioner and licensed producers, will use the Cannvas.Me platform for global interaction and cannabis education.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers. For additional information: www.cannvasmedtech.com.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/09/c3098.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: firstname.lastname@example.org, T: (800) 783-6056